All In Biotech

Drug Trial Radar · NCT05899608

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

A Randomized, Double-blind, Multiregional Phase 3 Study of Ivonescimab Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer (HARMONi-3)

Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,600 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,600

Planned (sponsor's estimate)

Start

Oct 26, 2023

Primary completion

Dec 31, 2028

Study completion Dec 31, 2029

Sponsor

Lead sponsor
Summit TherapeuticsIndustry
Sponsor type
Industry
First posted
Jun 12, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3 Randomized, double-blind, Multiregional Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer. The primary endpoint is overall survival and progression free survival assessed by investigator. The key secondary endpoints include response and safety.

Conditions

  • Non-Small Cell Lung Cancer

Interventions

  • Ivonescimab InjectionBiological

    Subject will receive ivonescimab and chemotherapy as an IV injection

  • Pembrolizumab InjectionBiological

    Subject will receive pembrolizumab and chemotherapy as an IV injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: approximately 4 years
  2. Progression Free Survival (PFS)Time frame: approximately 3 years

Locations

260 sites in 17 countries. Site status is shown where the registry gives one.

  • Banner University Medical Center

    Phoenix, Arizona

  • TMC Healthcare

    Tucson, Arizona

  • Genesis Cancer and Blood Institute

    Hot Springs, Arkansas

  • University of Arkansas

    Little Rock, Arkansas

  • LA Cancer Network

    Anaheim, California

  • The Oncology Institute of Hope & Innovation

    Cerritos, California

  • University of Southern California (USC)

    Los Angeles, California

  • Cedar Sinai Medical Center

    Los Angeles, California

  • Valkyrie Clinical Trials

    Los Angeles, California

  • Sutter Institute for Medical Research

    Sacramento, California

  • UC Davis Medical Center

    Sacramento, California

  • University of California Los Angeles (UCLA)

    Santa Monica, California

  • Providence Medical Foundation

    Santa Rosa, California

  • Kaiser Permanente

    Vallejo, California

  • Rocky Mountain Cancer

    Lone Tree, Colorado

  • Banner MD Anderson Cancer Center at North Colorado Medical Center

    Loveland, Colorado

  • Hartford Hospital

    Hartford, Connecticut

  • Yale University

    New Haven, Connecticut

  • Florida Cancer Specialists & Research Institute (FCS)-East

    Fort Myers, Florida

  • BioResearch Partner- Hialeah Hospital

    Hialeah, Florida

  • Memorial Healthcare System

    Hollywood, Florida

  • Mayo Clinic

    Jacksonville, Florida

  • Cancer Specialists of North Florida

    Jacksonville, Florida

  • Ocala Oncology

    Ocala, Florida

  • Cancer Care of Brevard

    Palm Bay, Florida

  • Ascension Sacred Heart Health System

    Pensacola, Florida

  • Exigent Network

    Petersburg, Florida

  • BRCR Medical Center Inc

    Plantation, Florida

  • Florida Cancer Specialists & Research Institute (FCS) - North

    St. Petersburg, Florida

  • BRCR Medical Center Inc.

    Tamarac, Florida

  • Florida Cancer Specialists & Research Institute (FCS)-South

    West Palm Beach, Florida

  • Central Georgia Cancer Care

    Macon, Georgia

  • Northwestern Memorial Hospital

    Chicago, Illinois

  • Illinois Cancer Care P.C.

    Peoria, Illinois

  • University of Kansas Cancer Center

    Westwood, Kansas

  • Baptist Health

    Lexington, Kentucky

  • Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland

  • Ascension Saint Agnes Hospital

    Baltimore, Maryland

  • Lahey Hospital

    Burlington, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

Showing 40 of 260 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.